papaverine has been researched along with Preterm Birth in 2 studies
Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Papaverine exposure was associated with higher rate of preterm delivery (22." | 5.62 | Pregnancy outcomes following gestational exposure to papaverine: An observational comparative study. ( Barchel, D; Berkovitch, M; Berlin, M; Braun, A; Gilan, A; Gueta, I; Kohn, E; Loebstein, R; Markovits, N, 2021) |
| "Papaverine exposure was associated with higher rate of preterm delivery (22." | 1.62 | Pregnancy outcomes following gestational exposure to papaverine: An observational comparative study. ( Barchel, D; Berkovitch, M; Berlin, M; Braun, A; Gilan, A; Gueta, I; Kohn, E; Loebstein, R; Markovits, N, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rzymski, P | 1 |
| Tomczyk, KM | 1 |
| Wilczak, M | 1 |
| Gueta, I | 1 |
| Braun, A | 1 |
| Gilan, A | 1 |
| Berlin, M | 1 |
| Kohn, E | 1 |
| Barchel, D | 1 |
| Markovits, N | 1 |
| Berkovitch, M | 1 |
| Loebstein, R | 1 |
2 other studies available for papaverine and Preterm Birth
| Article | Year |
|---|---|
The Influence of Oral Drotaverine Administration on Materno-Fetal Circulation during the Second and Third Trimester of Pregnancy.
Topics: Administration, Oral; Female; Humans; Infant, Newborn; Papaverine; Pregnancy; Pregnancy Trimester, S | 2022 |
Pregnancy outcomes following gestational exposure to papaverine: An observational comparative study.
Topics: Cesarean Section; Female; Gestational Age; Humans; Papaverine; Pregnancy; Pregnancy Outcome; Prematu | 2021 |